Skip to main content
. 2024 Jan 24;4(3):100264. doi: 10.1016/j.xjidi.2024.100264

Table 5.

Adverse Effects

Therapy Injection-Site Reaction Flu-like Symptoms Dyspigmentation Bullae/Vesicles Desquamation
MMR (n = 24) 92% (N = 22) 46% (N = 11) 4% (N = 1)
PPD (n = 19) 90% (N = 18) 35% (N = 7) 25% (N = 5) 20% (N = 4) 5% (N = 1)
Vitamin D3 (n = 15) 93% (N = 14) 20% (N = 3) 7% (N = 1)
Candida (n = 14) 93% (N = 13) 79% (N = 11) 7% (N = 1) 14% (N = 2) 7% (N = 1)

Abbreviations: MMR, measles, mumps, rubella vaccine; PPD, purified protein derivative.

n = number of studies including each respective therapy that reported any adverse effects. N = number of studies reporting that specific adverse effect. The number of studies reporting specific adverse effects for each of the most common therapies is shown.